| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.743 | 0.023 | 0.743 | Antiinflammatory | 0.647 0.041 DBMET03545 0.665 0.038 DBMET03546 0.736 0.024 DBMET03547 0.693 0.032 DBMET03548 | ||
| 0.618 | 0.002 | 0.618 | Tyk2 inhibitor | 0.573 0.003 DBMET03545 0.552 0.003 DBMET03546 0.617 0.002 DBMET03547 0.398 0.004 DBMET03548 | ||
| 0.593 | 0.011 | 0.707 | Tyrosine kinase inhibitor | 0.51 0.017 DBMET03545 0.307 0.041 DBMET03546 0.707 0.006 DBMET03547 0.131 0.1 DBMET03548 | DBMET03547 | |
| 0.441 | 0.082 | 0.441 | MAP kinase 1 inhibitor | 0.369 0.124 DBMET03545 0.429 0.089 DBMET03546 0.44 0.083 DBMET03547 | ||
| 0.406 | 0.052 | 0.505 | Angiogenesis inhibitor | 0.435 0.043 DBMET03545 0.505 0.029 DBMET03546 0.404 0.052 DBMET03547 | DBMET03546 | |
| 0.407 | 0.057 | 0.445 | Toll-Like receptor 7 agonist | 0.223 0.174 DBMET03545 0.445 0.045 DBMET03547 | DBMET03547 | |
| 0.399 | 0.061 | 0.441 | Toll-Like receptor agonist | 0.214 0.186 DBMET03545 0.441 0.046 DBMET03547 | DBMET03547 | |
| 0.207 | 0.011 | 0.229 | ALK inhibitor | 0.229 0.009 DBMET03545 0.115 0.032 DBMET03546 0.218 0.01 DBMET03547 0.075 0.067 DBMET03548 | DBMET03545 | |
| 0.253 | 0.065 | 0.253 | HERG channel blocker | 0.185 0.1 DBMET03545 0.236 0.072 DBMET03546 0.231 0.074 DBMET03547 | ||
| 0.245 | 0.069 | 0.245 | Potassium channel (Voltage-sensitive) blocker | 0.181 0.111 DBMET03545 0.22 0.083 DBMET03546 0.22 0.083 DBMET03547 | ||
| 0.189 | 0.038 | 0.189 | Phosphodiesterase inhibitor | 0.122 0.08 DBMET03545 0.122 0.08 DBMET03546 0.184 0.04 DBMET03547 | ||
| 0.166 | 0.024 | 0.249 | MAP kinase 8 inhibitor | 0.208 0.015 DBMET03545 0.102 0.058 DBMET03546 0.249 0.01 DBMET03547 | DBMET03547 | |
| 0.206 | 0.065 | 0.232 | Focal adhesion kinase 2 inhibitor | 0.222 0.053 DBMET03545 0.232 0.047 DBMET03547 | DBMET03547 | |
| 0.175 | 0.036 | 0.228 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.228 0.021 DBMET03545 0.133 0.058 DBMET03546 0.093 0.092 DBMET03547 | DBMET03545 | |
| 0.174 | 0.036 | 0.228 | Abl kinase inhibitor | 0.228 0.021 DBMET03545 0.132 0.058 DBMET03546 | DBMET03545 | |
| 0.18 | 0.05 | 0.224 | Vascular endothelial growth factor 3 antagonist | 0.21 0.038 DBMET03545 0.224 0.033 DBMET03547 | DBMET03547 | |
| 0.16 | 0.034 | 0.273 | MAP kinase 9 inhibitor | 0.273 0.014 DBMET03545 0.228 0.018 DBMET03547 | DBMET03545 | |
| 0.181 | 0.057 | 0.251 | Polo-like kinase-3 inhibitor | 0.15 0.084 DBMET03545 0.251 0.024 DBMET03547 | DBMET03547 | |
| 0.159 | 0.038 | 0.181 | Vascular endothelial growth factor 1 antagonist | 0.168 0.035 DBMET03545 0.181 0.031 DBMET03547 | DBMET03547 | |
| 0.165 | 0.049 | 0.194 | Vascular endothelial growth factor antagonist | 0.194 0.04 DBMET03545 0.095 0.086 DBMET03546 0.18 0.044 DBMET03547 | DBMET03545 | |
| 0.133 | 0.019 | 0.145 | MAP kinase 10 inhibitor | 0.145 0.017 DBMET03545 0.077 0.055 DBMET03546 0.128 0.021 DBMET03547 | DBMET03545 | |
| 0.238 | 0.125 | 0.372 | Immunomodulator | 0.313 0.075 DBMET03546 0.261 0.107 DBMET03547 0.372 0.053 DBMET03548 | DBMET03548 | |
| 0.125 | 0.014 | 0.125 | Janus tyrosine kinase 1 inhibitor | 0.111 0.019 DBMET03545 0.054 0.043 DBMET03546 0.11 0.019 DBMET03547 | ||
| 0.157 | 0.057 | 0.184 | MAP kinase 3 inhibitor | 0.184 0.032 DBMET03547 0.125 0.12 DBMET03548 | DBMET03547 | |
| 0.154 | 0.067 | 0.235 | Growth factor antagonist | 0.141 0.075 DBMET03545 0.235 0.038 DBMET03547 | DBMET03547 | |
| 0.103 | 0.025 | 0.124 | Adenosine A3 receptor antagonist | 0.112 0.021 DBMET03547 0.124 0.017 DBMET03548 | DBMET03548 | |
| 0.11 | 0.036 | 0.133 | Leucine-rich repeat kinase 2 inhibitor | 0.073 0.065 DBMET03545 0.133 0.026 DBMET03547 | DBMET03547 | |
| 0.176 | 0.11 | 0.176 | Potassium channel blocker | 0.161 0.125 DBMET03546 0.152 0.133 DBMET03547 | ||
| 0.115 | 0.062 | 0.136 | Vascular endothelial growth factor 2 antagonist | 0.136 0.054 DBMET03545 0.123 0.059 DBMET03547 | DBMET03545 | |
| 0.09 | 0.038 | 0.104 | Focal adhesion kinase 1 inhibitor | 0.091 0.038 DBMET03545 0.104 0.027 DBMET03547 | DBMET03547 | |
| 0.12 | 0.068 | 0.144 | Tyrosine-protein kinase receptor FLT3 inhibitor | 0.144 0.056 DBMET03545 0.092 0.085 DBMET03547 | DBMET03545 | |
| 0.114 | 0.067 | 0.25 | Glycogen synthase kinase-3 inhibitor | 0.25 0.022 DBMET03545 0.117 0.064 DBMET03547 | DBMET03545 | |
| 0.068 | 0.029 | 0.071 | Fibroblast growth factor 4 antagonist | 0.071 0.026 DBMET03547 | DBMET03547 | |
| 0.058 | 0.025 | 0.07 | Antiviral (Hepatitis D) | 0.07 0.014 DBMET03547 | DBMET03547 | |
| 0.077 | 0.046 | 0.095 | Polo-like kinase-2 inhibitor | 0.095 0.031 DBMET03547 | DBMET03547 | |
| 0.114 | 0.084 | 0.159 | RET inhibitor | 0.159 0.057 DBMET03545 0.15 0.061 DBMET03547 | DBMET03545 | |
| 0.156 | 0.128 | 0.16 | MAP kinase kinase 5 inhibitor | 0.16 0.116 DBMET03545 0.154 0.137 DBMET03547 | DBMET03545 | |
| 0.051 | 0.024 | 0.058 | Benzodiazepine inverse agonist | 0.043 0.042 DBMET03546 0.058 0.016 DBMET03547 | DBMET03547 | |
| 0.092 | 0.066 | 0.099 | CDK2/cyclin A inhibitor | 0.099 0.059 DBMET03545 | DBMET03545 | |
| 0.085 | 0.063 | 0.085 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.078 0.074 DBMET03547 | ||
| 0.069 | 0.049 | 0.079 | ZAP-70 protein tyrosine kinase inhibitor | 0.071 0.047 DBMET03545 0.079 0.036 DBMET03547 | DBMET03547 | |
| 0.099 | 0.079 | 0.198 | Glycogen synthase kinase-3 beta inhibitor | 0.198 0.029 DBMET03545 0.097 0.082 DBMET03547 | DBMET03545 | |
| 0.122 | 0.107 | 0.148 | CC chemokine 6 receptor antagonist | 0.148 0.025 DBMET03545 0.127 0.082 DBMET03547 0.136 0.05 DBMET03548 | DBMET03545 | |
| 0.086 | 0.073 | 0.128 | Platelet activating factor beta antagonist | 0.128 0.046 DBMET03545 0.098 0.064 DBMET03547 | DBMET03545 | |
| 0.101 | 0.09 | 0.143 | Cyclin-dependent kinase inhibitor | 0.143 0.06 DBMET03545 0.097 0.093 DBMET03547 | DBMET03545 | |
| 0.075 | 0.067 | 0.083 | ErbB-3 antagonist | 0.083 0.057 DBMET03547 | DBMET03547 | |
| 0.064 | 0.06 | 0.082 | Macrophage colony-stimulating factor 1 receptor antagonist | 0.082 0.039 DBMET03547 | DBMET03547 | |
| 0.046 | 0.045 | 0.064 | CXC chemokine 1 receptor antagonist | 0.064 0.018 DBMET03546 0.054 0.03 DBMET03547 | DBMET03546 | |
| 0.015 | 0.016 | 0.021 | Adenosine A3 receptor agonist | 0.016 0.013 DBMET03547 0.021 0.008 DBMET03548 | DBMET03548 | |
| 0.081 | 0.083 | 0.137 | Aurora-A kinase inhibitor | 0.137 0.046 DBMET03545 0.086 0.078 DBMET03547 | DBMET03545 | |
| 0.118 | 0.121 | 0.134 | Death-associated protein kinase 1 inhibitor | 0.134 0.07 DBMET03545 | DBMET03545 | |
| 0.095 | 0.106 | 0.126 | Epidermal growth factor receptor kinase inhibitor | 0.101 0.097 DBMET03545 0.126 0.067 DBMET03547 | DBMET03547 | |
| 0.068 | 0.079 | 0.075 | Bcr-Abl kinase inhibitor | 0.075 0.071 DBMET03547 | DBMET03547 | |
| 0.07 | 0.082 | 0.088 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.079 0.073 DBMET03545 0.088 0.064 DBMET03547 | DBMET03547 | |
| 0.071 | 0.084 | 0.077 | MAP kinase 7 inhibitor | 0.077 0.055 DBMET03547 | DBMET03547 | |
| 0.133 | 0.146 | 0.148 | Cyclin-dependent kinase 3 inhibitor | 0.148 0.102 DBMET03545 | DBMET03545 | |
| 0.072 | 0.087 | 0.089 | Factor XII inhibitor | 0.089 0.051 DBMET03547 | DBMET03547 | |
| 0.058 | 0.077 | 0.097 | MAP3K7 inhibitor | 0.097 0.024 DBMET03547 | DBMET03547 | |
| 0.105 | 0.127 | 0.123 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.123 0.103 DBMET03545 | DBMET03545 | |
| 0.061 | 0.084 | 0.073 | Platelet growth factor antagonist | 0.073 0.065 DBMET03547 | DBMET03547 | |
| 0.07 | 0.095 | 0.096 | Platelet activating factor alpha antagonist | 0.096 0.063 DBMET03545 | DBMET03545 | |
| 0.078 | 0.105 | 0.125 | Cyclin-dependent kinase 2 inhibitor | 0.125 0.049 DBMET03545 | DBMET03545 | |
| 0.126 | 0.153 | 0.203 | Antimitotic | 0.203 0.082 DBMET03545 | DBMET03545 | |
| 0.065 | 0.096 | 0.087 | Epidermal growth factor antagonist | 0.087 0.057 DBMET03547 | DBMET03547 | |
| 0.047 | 0.081 | 0.077 | Syk tyrosine kinase inhibitor | 0.064 0.055 DBMET03545 0.077 0.043 DBMET03547 | DBMET03547 | |
| 0.058 | 0.094 | 0.113 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.113 0.029 DBMET03547 | DBMET03547 | |
| 0.028 | 0.065 | 0.034 | ATM kinase inhibitor | 0.034 0.032 DBMET03547 | DBMET03547 | |
| 0.053 | 0.094 | 0.079 | TIE antagonist | 0.079 0.06 DBMET03547 | DBMET03547 | |
| 0.07 | 0.113 | 0.102 | Polo-like kinase-1 inhibitor | 0.102 0.044 DBMET03547 | DBMET03547 | |
| 0.113 | 0.159 | 0.171 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.171 0.1 DBMET03545 | DBMET03545 | |
| 0.07 | 0.116 | 0.13 | Granulocyte macrophage colony stimulating factor antagonist | 0.115 0.057 DBMET03545 0.13 0.046 DBMET03547 | DBMET03547 | |
| 0.123 | 0.171 | 0.163 | Dyrk kinase inhibitor | 0.163 0.124 DBMET03545 0.162 0.125 DBMET03547 | DBMET03545 | |
| 0.115 | 0.173 | 0.153 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.134 0.131 DBMET03545 0.153 0.109 DBMET03547 | DBMET03547 | |
| 0.046 | 0.106 | 0.074 | TIE-2 antagonist | 0.074 0.064 DBMET03547 | DBMET03547 | |
| 0.026 | 0.094 | 0.07 | Adenosine A1 receptor antagonist | 0.07 0.033 DBMET03548 | DBMET03548 | |
| 0.101 | 0.169 | 0.144 | Clk dual-specificity kinase inhibitor | 0.144 0.12 DBMET03545 | DBMET03545 | |
| 0.072 | 0.142 | 0.147 | MAP kinase kinase inhibitor | 0.147 0.053 DBMET03545 | DBMET03545 | |
| 0.083 | 0.157 | 0.132 | CDC-like kinase 2 inhibitor | 0.132 0.107 DBMET03545 | DBMET03545 | |
| 0.057 | 0.143 | 0.099 | Platelet activating factor antagonist | 0.099 0.079 DBMET03545 | DBMET03545 | |
| 0.101 | 0.189 | 0.196 | EphB2 antagonist | 0.196 0.09 DBMET03547 | DBMET03547 | |
| 0.061 | 0.151 | 0.106 | Protein-tyrosine kinase Lyn inhibitor | 0.106 0.097 DBMET03547 | DBMET03547 | |
| 0.09 | 0.184 | 0.14 | Heat shock protein 90 antagonist | 0.14 0.085 DBMET03547 | DBMET03547 | |
| 0.059 | 0.155 | 0.087 | Phosphodiesterase 7B inhibitor | 0.087 0.075 DBMET03547 | DBMET03547 | |
| 0.071 | 0.181 | 0.115 | Src kinase inhibitor | 0.115 0.112 DBMET03547 | DBMET03547 | |
| 0.105 | 0.216 | 0.139 | MAP kinase kinase 4 inhibitor | 0.139 0.086 DBMET03545 0.128 0.119 DBMET03547 | DBMET03545 | |
| 0.006 | 0.16 | 0.026 | Adenosine A1 receptor agonist | 0.026 0.015 DBMET03548 | DBMET03548 | |
| 0.015 | 0.174 | 0.053 | Phosphatidylinositol 3-kinase delta inhibitor | 0.053 0.044 DBMET03547 | DBMET03547 | |
| 0.014 | 0.18 | 0.054 | Adenosine A2a receptor antagonist | 0.054 0.051 DBMET03547 | DBMET03547 | |
| 0.062 | 0.239 | 0.105 | CDK3/cyclin E inhibitor | 0.105 0.078 DBMET03545 | DBMET03545 | |
| 0.036 | 0.256 | 0.066 | MAP kinase kinase 8 inhibitor | 0.066 0.052 DBMET03545 | DBMET03545 | |
| 0.106 | 0.337 | 0.227 | Nootropic | 0.227 0.128 DBMET03546 | DBMET03546 | |
| 0.088 | 0.339 | 0.143 | Death-associated protein kinase 2 inhibitor | 0.143 0.122 DBMET03545 | DBMET03545 | |
| 0.023 | 0.298 | 0.251 | M18 aspartyl aminopeptidase inhibitor | 0.251 0.021 DBMET03545 | DBMET03545 | |
| 0.028 | 0.306 | 0.185 | M17 leucyl aminopeptidase inhibitor | 0.185 0.038 DBMET03545 | DBMET03545 | |
| 0.019 | 0.459 | 0.087 | Aminoacyl-tRNA synthetase inhibitor | 0.087 0.064 DBMET03548 | DBMET03548 | |
| 0.029 | 0.477 | 0.115 | DNA polymerase I inhibitor | 0.115 0.072 DBMET03548 | DBMET03548 | |
| 0.087 | 0.537 | 0.264 | Peptidyltransferase inhibitor | 0.264 0.042 DBMET03548 | DBMET03548 | |
| 0.025 | 0.588 | 0.119 | mTOR complex 1 inhibitor | 0.119 0.03 DBMET03545 | DBMET03545 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |